ATE459883T1 - Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose - Google Patents
Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnoseInfo
- Publication number
- ATE459883T1 ATE459883T1 AT05715950T AT05715950T ATE459883T1 AT E459883 T1 ATE459883 T1 AT E459883T1 AT 05715950 T AT05715950 T AT 05715950T AT 05715950 T AT05715950 T AT 05715950T AT E459883 T1 ATE459883 T1 AT E459883T1
- Authority
- AT
- Austria
- Prior art keywords
- diagnosis
- cancer prognosis
- proliferation markers
- clinical practice
- new proliferation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54811104P | 2004-02-27 | 2004-02-27 | |
PCT/EP2005/002578 WO2005085860A2 (en) | 2004-02-27 | 2005-02-28 | New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE459883T1 true ATE459883T1 (de) | 2010-03-15 |
Family
ID=34919336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05715950T ATE459883T1 (de) | 2004-02-27 | 2005-02-28 | Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose |
Country Status (7)
Country | Link |
---|---|
US (2) | US7781174B2 (de) |
EP (1) | EP1721165B1 (de) |
JP (1) | JP4848355B2 (de) |
AT (1) | ATE459883T1 (de) |
CA (1) | CA2555656C (de) |
DE (1) | DE602005019694D1 (de) |
WO (1) | WO2005085860A2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11254916B2 (en) | 2006-03-02 | 2022-02-22 | Viacyte, Inc. | Methods of making and using PDX1-positive pancreatic endoderm cells |
CA3147112A1 (en) | 2006-03-02 | 2007-09-13 | Viacyte, Inc. | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
US20100144830A1 (en) * | 2006-09-19 | 2010-06-10 | Masahiko Kuroda | Cancer cell identification marker and cancer cell proliferation inhibitor |
EP2155692B1 (de) | 2007-05-30 | 2015-06-17 | F. Hoffmann-La Roche AG | Nicht-nukleosidische reverse-transkriptase-hemmer |
US20110059464A1 (en) * | 2008-04-08 | 2011-03-10 | Muraca Patrick J | Biomarker Panel For Prediction Of Recurrent Colorectal Cancer |
EP2243843A1 (de) * | 2009-04-24 | 2010-10-27 | Institut Curie | HP1-Alpha als prognostischer Marker bei Krebserkrankungen des Menschen |
WO2011151321A1 (en) | 2010-05-31 | 2011-12-08 | Institut Curie | Asf1b as a prognosis marker and therapeutic target in human cancer |
EP2702173A1 (de) | 2011-04-25 | 2014-03-05 | OSI Pharmaceuticals, LLC | Verwendung von emt-gensignaturen bei der entdeckung von krebswirkstoffen, -diagnostika und -behandlungen |
JP6854246B2 (ja) | 2015-06-08 | 2021-04-07 | アーケア ダイアグノスティクス リミテッド | 尿サンプルの分析方法 |
EP3304084B1 (de) | 2015-06-08 | 2022-03-23 | Arquer Diagnostics Limited | Verfahren und kits |
JP6841609B2 (ja) | 2015-07-10 | 2021-03-10 | 3スキャン インコーポレイテッド | 組織学的染色の空間的多重化 |
CN110573629A (zh) * | 2017-03-30 | 2019-12-13 | 伊利诺伊大学理事会 | 用于诊断早期胰腺癌的方法和试剂盒 |
KR102655467B1 (ko) | 2018-02-28 | 2024-04-08 | 니토 보세키 가부시기가이샤 | 고정화 세포 또는 ffpe 조직 절편으로부터 항원성을 증강한 세포핵을 탈리하는 방법 그리고 그것을 위한 항원 부활제 및 키트 |
CN111766385B (zh) * | 2020-07-06 | 2023-09-26 | 河南赛诺特生物技术有限公司 | 术中快速鉴别肺癌和硬化性肺细胞瘤的免疫组化试剂盒 |
CN113984483B (zh) * | 2021-09-28 | 2023-10-20 | 福建医科大学 | 一种冰冻切片盖玻片贴片染色方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071715A (en) * | 1993-08-12 | 2000-06-06 | Board Of Regents, The University Of Texas System | Nucleic acids encoding novel proteins which bind to retinoblastoma protein |
CN100342030C (zh) * | 2000-11-24 | 2007-10-10 | 卫材R&D管理有限公司 | 试验肿瘤细胞对于抗癌药剂敏感性的方法 |
JP2005518782A (ja) * | 2001-09-17 | 2005-06-30 | プロテイン デザイン ラブス, インコーポレイテッド | ガンの診断方法、ガンのモジュレータのスクリーニング組成物及び方法 |
US20040005644A1 (en) * | 2002-02-28 | 2004-01-08 | Su Yan A. | Method and composition for detection and treatment of breast cancer |
-
2005
- 2005-02-28 JP JP2007500191A patent/JP4848355B2/ja not_active Expired - Fee Related
- 2005-02-28 WO PCT/EP2005/002578 patent/WO2005085860A2/en active Application Filing
- 2005-02-28 CA CA2555656A patent/CA2555656C/en not_active Expired - Fee Related
- 2005-02-28 EP EP05715950A patent/EP1721165B1/de not_active Not-in-force
- 2005-02-28 AT AT05715950T patent/ATE459883T1/de not_active IP Right Cessation
- 2005-02-28 DE DE602005019694T patent/DE602005019694D1/de active Active
-
2006
- 2006-08-28 US US11/510,612 patent/US7781174B2/en not_active Expired - Fee Related
-
2010
- 2010-06-03 US US12/792,855 patent/US20110003706A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1721165A2 (de) | 2006-11-15 |
US20070077577A1 (en) | 2007-04-05 |
JP2007524103A (ja) | 2007-08-23 |
US7781174B2 (en) | 2010-08-24 |
JP4848355B2 (ja) | 2011-12-28 |
EP1721165B1 (de) | 2010-03-03 |
DE602005019694D1 (de) | 2010-04-15 |
WO2005085860A3 (en) | 2005-11-10 |
US20110003706A1 (en) | 2011-01-06 |
CA2555656C (en) | 2017-03-28 |
WO2005085860A2 (en) | 2005-09-15 |
CA2555656A1 (en) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE459883T1 (de) | Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose | |
ATE430936T1 (de) | Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome | |
EP2535716A3 (de) | Krebsmarker und therapeutisches Target | |
ATE511857T1 (de) | Anti-april monoklonaler antikörper und deren verwendung zur behandlung von immunerkrankungen oder krebs | |
ATE490465T1 (de) | Diagnose- und prognoseverfahren von blasenkrebs. | |
WO2006047484A3 (en) | Molecular analysis of cellular fluid and liquid cytology specimens for clinical diagnosis, characterization, and integration with microscopic pathology evaluation | |
ATE479898T1 (de) | Reagenzien und verfahren zur verwendung bei der diagnose, klassifizierung und behandlung von krebs | |
ATE519110T1 (de) | Diagnostischer nanosensor und dessen verwendung in der medizin | |
MX2007006529A (es) | Seleccionar pacientes para terapia con un inhibidor her. | |
WO2008115518A3 (en) | Biomarkers of sirtuin activity and methods of use thereof | |
WO2007092433A3 (en) | Osteoporosis associated markers and methods of use thereof | |
SG10201804260QA (en) | Diagnostic assays and kits for detection of folate receptor 1 | |
WO2008109414A3 (en) | Use of endogenous fluorescence to identify invading metastatic breast tumor cells | |
NZ578283A (en) | Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring | |
WO2010118166A3 (en) | Methods of predicting cancer risk using gene expression in premalignant tissue | |
DE602005024964D1 (de) | Verfahren zur beurteilung der malignität einer säuger-krebszelle | |
MX2020002122A (es) | Sustancias de control de calidad para uso con analizadores de sedimentos en orina basados en microscopia, y metodos de uso. | |
WO2007146668A3 (en) | Use of imp3 as a prognostic marker for cancer | |
BR0317394A (pt) | Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal | |
MY193895A (en) | Combination test for colorectal cancer | |
ATE545867T1 (de) | I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom | |
PE20120592A1 (es) | Metodo con biomarcadores para el seguimiento de un tratamiento | |
HK1136873A1 (en) | Use of nnmt as a marker for lung cancer | |
ATE426168T1 (de) | Verwendung von asc als marker fur kolorektalkarzinome | |
EP2539709A4 (de) | Morbus-alzheimer-spezifische änderungen von proteinkinase-c-epsilon- (pkc-epsilon-)proteinspiegeln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |